상세 보기
- Yong, Hyo Jeong;
- Park, Jeong Su;
- Jeong, Ae Lee;
- Han, Sora;
- Lee, Sunyi;
- ... Yang, Young;
- 외 9명
WEB OF SCIENCE
6SCOPUS
8초록
Hypoxia-induced interleukin-32 beta (IL-32 beta) shifts the metabolic program to the enhanced glycolytic pathway. In the present study, the underlying mechanism by which hypoxia-induced IL-32 beta stability is regulated was investigated in ovarian cancer cells. IL-32 beta expression increased under hypoxic conditions in ovarian cancer cells as it did in breast cancer cells. The amount of IL-32 beta was regulated by post-translational control rather than by transcriptional activation. Under normoxic conditions, IL-32 beta was continuously eliminated through ubiquitin-dependent degradation by the von-Hippel Lindau (VHL) E3 ligase complex. Oxygen deficiency or reactive oxygen species (ROS) disrupted the interaction between IL-32 beta and VHL, leading to the accumulation of the cytokine. The fact that IL-32 beta is regulated by the energy-consuming ubiquitination system implies that it plays an important role in oxidative stress. We found that IL-32 beta reduced protein kinase C delta (PKC delta)-induced apoptosis under oxidative stress. This implies that the hypoxia- and ROS-stabilized IL-32 beta contributes to sustain survival against PKC delta-induced apoptosis.
키워드
- 제목
- Von Hippel-Lindau regulates interleukin-32 beta stability in ovarian cancer cells
- 저자
- Yong, Hyo Jeong; Park, Jeong Su; Jeong, Ae Lee; Han, Sora; Lee, Sunyi; Ka, Hye In; Sumiyasuren, Buyanravjkh; Joo, Hyun Jeong; So, Su Jeong; Park, Ji Young; Yoon, Do-Young; Lim, Jong-Seok; Lee, Myeong-Seok; Lee, Hee Gu; Yang, Young
- 발행일
- 2017-09
- 유형
- Article
- 저널명
- Oncotarget
- 권
- 8
- 호
- 41
- 페이지
- 69833 ~ 69846